Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Eureka Genomics' Proton Services; Roche's GS FLX+ Software

Premium

Eureka Genomics is now offering next-generation sequencing services on Life Technologies' Ion Proton. Initially, the service will focus on library preparation and sequence data generation, with services to expand to target enrichment of gene panels and the exome, and complete data analysis.


Roche has launched software v2.9 for it 454 GS FLX+ system, which extends amplicon read lengths to 800 bases for targeted sequencing projects while maintaining greater than 99 percent accuracy, according to the company.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.